Skip to content

PMCF Study to Examine the Debridement Pad Cutimed DebriClean

Post Market Clinical Follow up Study to Examine Clinical Performance of the Debridement Pad Cutimed DebriClean

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04731753
Enrollment
62
Registered
2021-02-01
Start date
2021-04-27
Completion date
2022-05-30
Last updated
2022-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound

Keywords

Debridement

Brief summary

Documentation of the performance and safety of the debridement pad Cutimed DebriClean in daily clinical practice

Detailed description

60 subjects with superficial wounds in need of debridement will undergo mechanical debridement with the study product. Per subject, one application of the study product will be documented including photo documentation of the wound and evaluation of the wound bed condition and wound size before and after the debridement.

Interventions

The mechanical debridement is performed using the debridement pad Cutimed DebriClean. After the pad is moistened with wound-cleansing solution, the wound is cleaned using circular movements while applying gentle pressure.

Sponsors

BSN Medical GmbH
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female subjects aged 18 years or older with full legal competence * Signed informed consent * Subjects with wounds in need of debridement, especially diabetic ulcers, venous and arterial ulcers, pressure sores, postoperative wounds and wounds healing by secondary intention, superficial burns * Superficial wound * Minimum 30 % of the wound is covered by debris, necrosis or slough * Wound size \> 4 cm²

Exclusion criteria

* Subjects not willing to participate or to attend the scheduled study visit * Known sensitivity or allergy to the product components * Severe pain or hyperaesthesia in the wound area * Patients who are pregnant or lactating * Drug abuse or alcohol abuse * Patients who participate in any other clinical study investigating drugs or medical devices

Design outcomes

Primary

MeasureTime frameDescription
Change of wound bed condition from baseline to assessment immediately after the mechanical debridement (within one study visit)assessed immediately before and immediately after the mechanical debridement (within one study visit)Percentage of wound coverage with debris/necrosis/slough Wound edge cleaned smooth Surrounding skin cleaned e.g. from skin flakes

Secondary

MeasureTime frameDescription
Wound size after and before wound debridementassessed immediately before and immediately after the mechanical debridement (within one study visit)Wound length and wound width are measured using a wound ruler. Wound size is calculated using the formula A = length x width x π/4.
Debris/necrosis/slough absorbed by test productassessed immediately after the mechanical debridementassessed by the investigator (five categories)
Time needed for the debridement procedureTime is measured during the debridement procedureTime from start to completion of the debridement procedure in minutes
Pain during the debridement procedureassessed immediately after the debridement procedurePatient reported pain assessed using a visual analogue scale. If applicable, duration of pain is documented.
Adverse device effectsassessed immediately after the debridement procedureDiscomfort, pressure, burning sensation, bleeding, and irritation of the periwound skin during or after the mechanical debridement, other adverse device effects swelling; redness
Structural integrity of the test productassessed immediately after the mechanical debridementassessed by the investigator (e.g. change in shape, loosening of fibers, …)

Countries

Germany, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026